P54 nrb/NONO regulates lipid metabolism and breast cancer growth through SREBP-1A

Oncogene

Volumn 35, Issue 11, 2016, Pages 1399-1410

  Zhu, Z ^a   Zhao, X ^a   Zhao, L ^a   Yang, H ^b   Liu, L ^a   Li, J ^a   Wu, J ^a   Yang, F ^c   Huang, G ^a,b   Liu, J ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; NUCLEAR PROTEIN; P54 NRB NONO PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1A; TYROSINE; UNCLASSIFIED DRUG; NONO PROTEIN, HUMAN; NUCLEAR MATRIX PROTEIN; OCTAMER TRANSCRIPTION FACTOR; PROTEIN BINDING; RNA BINDING PROTEIN; SMALL INTERFERING RNA;

ADULT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER GROWTH; CANCER PATIENT; CANCER TISSUE; CELL GROWTH; CELL NUCLEUS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE TARGETING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIPID METABOLISM; LIPOGENESIS; MIDDLE AGED; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; CANCER TRANSPLANTATION; GENETICS; MCF 7 CELL LINE; METABOLISM; RNA INTERFERENCE; SCID MOUSE; TUMOR CELL LINE; UPREGULATION; XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; FEMALE; HUMANS; LIPID METABOLISM; MCF-7 CELLS; MICE; MICE, INBRED BALB C; MICE, SCID; MIDDLE AGED; NEOPLASM TRANSPLANTATION; NUCLEAR MATRIX-ASSOCIATED PROTEINS; OCTAMER TRANSCRIPTION FACTORS; PROTEIN BINDING; RNA INTERFERENCE; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION;

EID: 84935421424     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.197     Document Type: Article

References (47)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30.
2. Ferlay J, Soerjomataram II, Dikshit R, Eser S, Mathers C, Rebelo M et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2014; 136: E359-E386.
3. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
4. Tennant DA, Duran RV, Gottlieb E. Targeting metabolic transformation for cancer therapy. Nat Rev Cancer 2010; 10: 267-277.
5. Furuta E, Pai SK, Zhan R, Bandyopadhyay S, Watabe M, Mo YY et al. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Res 2008; 68: 1003-1011.
6. Lu S, Archer MC. Sp1 coordinately regulates de novo lipogenesis and proliferation in cancer cells. Int J Cancer 2010; 126: 416-425.
7. Park J, Morley TS, Kim M, Clegg DJ, Scherer PE. Obesity and cancer-mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol 2014; 10: 455-465.
8. Shav-Tal Y, Zipori D. PSF and p54(nrb)/NonO-multi-functional nuclear proteins. FEBS Lett 2002; 531: 109-114.
9. Zhang Z, Carmichael GG. The fate of dsRNA in the nucleus: a p54(nrb)-containing complex mediates the nuclear retention of promiscuously A-to-I edited RNAs. Cell 2001; 106: 465-475.
10. Hata K, Nishimura R, Muramatsu S, Matsuda A, Matsubara T, Amano K et al. Paraspeckle protein p54nrb links Sox9-mediated transcription with RNA processing during chondrogenesis in mice. J Clin Invest 2008; 118: 3098-3108.
11. Ishiguro H, Uemura H, Fujinami K, Ikeda N, Ohta S, Kubota Y. 55 kDa nuclear matrix protein (nmt55) mRNA is expressed in human prostate cancer tissue and is associated with the androgen receptor. Int J Cancer 2003; 105: 26-32.
12. Schiffner S, Zimara N, Schmid R, Bosserhoff AK. p54nrb is a new regulator of progression malignant melanoma. Carcinogenesis 2011; 32: 1176-1182.
13. Liu PY, Erriquez D, Marshall GM, Tee AE, Polly P, Wong M et al. Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression. J Natl Cancer Inst 2014; 106:
14. Pavao M, Huang YH, Hafer LJ, Moreland RB, Traish AM. Immunodetection of nmt55/p54nrb isoforms in human breast cancer. BMC Cancer 2001; 1: 15.
15. Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X et al. SREBP-1, a basichelix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 1993; 75: 187-197.
16. Zhao X, Xiaoli, Zong H, Abdulla A, Yang ES, Ji JY et al. Inhibition of SREBP transcriptional activity by a boron-containing compound improves lipid homeostasis in diet-induced obesity. Diabetes 2014; 63: 2464-2473.
17. Shao W, Espenshade PJ. Expanding Roles for SREBP in Metabolism. Cell Metab 2012; 16: 414-419.
18. Shimomura I, Shimano H, Horton JD, Goldstein JL, Brown MS. Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J Clin Invest 1997; 99: 838-845.
19. Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002; 109: 1125-1131.
20. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007; 7: 763-777.
21. Li JN, Mahmoud MA, Han WF, Ripple M, Pizer ES. Sterol regulatory elementbinding protein-1 participates in the regulation of fatty acid synthase expression in colorectal neoplasia. Exp Cell Res 2000; 261: 159-165.
22. Heemers H, Maes B, Foufelle F, Heyns W, Verhoeven G, Swinnen JV. Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway. Mol Endocrinol 2001; 15: 1817-1828.
23. Yang Y, Morin PJ, Han WF, Chen T, Bornman DM, Gabrielson EW et al. Regulation of fatty acid synthase expression in breast cancer by sterol regulatory element binding protein-1c. Exp Cell Res 2003; 282: 132-137.
24. Guo D, Prins RM, Dang J, Kuga D, Iwanami A, Soto H et al. EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. Sci Signal 2009; 2: ra82.
25. Freed-Pastor WA, Mizuno H, Zhao X, Langerod A, Moon SH, Rodriguez-Barrueco R et al. Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell 2012; 148: 244-258.
26. Yecies JL, Zhang HH, Menon S, Liu S, Yecies D, Lipovsky AI et al. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab 2011; 14: 21-32.
27. Williams KJ, Argus JP, Zhu Y, Wilks MQ, Marbois BN, York AG et al. An essential requirement for the SCAP/SREBP signaling axis to protect cancer cells from lipotoxicity. Cancer Res 2013; 73: 2850-2862.
28. Guo D, Bell EH, Mischel P, Chakravarti A. Targeting SREBP-1-driven lipid metabolism to treat cancer. Curr Pharm Des 2014; 20: 2619-2626.
29. Amelio AL, Miraglia LJ, Conkright JJ, Mercer BA, Batalov S, Cavett V et al. A coactivator trap identifies NONO (p54nrb) as a component of the cAMPsignaling pathway. Proc Natl Acad Sci USA 2007; 104: 20314-20319.
30. Ishitani K, Yoshida T, Kitagawa H, Ohta H, Nozawa S, Kato S. p54nrb acts as a transcriptional coactivator for activation function 1 of the human androgen receptor. Biochem Biophys Res Commun 2003; 306: 660-665.
31. Passon DM, Lee M, Rackham O, Stanley WA, Sadowska A, Filipovska A et al. Structure of the heterodimer of human NONO and paraspeckle protein component 1 and analysis of its role in subnuclear body formation. Proc Natl Acad Sci USA 2012; 109: 4846-4850.
32. Kuwahara S, Ikei A, Taguchi Y, Tabuchi Y, Fujimoto N, Obinata M et al. PSPC1, NONO, and SFPQ are expressed in mouse Sertoli cells and may function as coregulators of androgen receptor-mediated transcription. Biol Reprod 2006; 75: 352-359.
33. Kuhnert A, Schmidt U, Monajembashi S, Franke C, Schlott B, Grosse F et al. Proteomic identification of PSF and p54(nrb) as TopBP1-interacting proteins. J Cell Biochem 2012; 113: 1744-1753.
34. Zhao X, Feng D, Wang Q, Abdulla A, Xie XJ, Zhou J et al. Regulation of lipogenesis by cyclin-dependent kinase 8-mediated control of SREBP-1. J Clin Invest 2012; 122: 2417-2427.
35. Sundqvist A, Bengoechea-Alonso MT, Ye X, Lukiyanchuk V, Jin J, Harper JW et al. Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCF(Fbw7). Cell Metab 2005; 1: 379-391.
36. Medes G, Thomas A, Weinhouse S. Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res 1953; 13: 27-29.
37. Nieva C, Marro M, Santana-Codina N, Rao S, Petrov D, Sierra A. The lipid phenotype of breast cancer cells characterized by Raman microspectroscopy: towards a stratification of malignancy. PLoS One 2012; 7: e46456.
38. Rysman E, Brusselmans K, Scheys K, Timmermans L, Derua R, Munck S et al. De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. Cancer Res 2010; 70: 8117-8126.
39. Currie E, Schulze A, Zechner R, Walther TC, Farese RV Jr. Cellular fatty acid metabolism and cancer. Cell Metab 2013; 18: 153-161.
40. Kuhajda FP. Fatty acid synthase and cancer: new application of an old pathway. Cancer Res 2006; 66: 5977-5980.
41. Milgraum LZ, Witters LA, Pasternack GR, Kuhajda FP. Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clin Cancer Res 1997; 3: 2115-2120.
42. Rawson RB. The SREBP pathway-insights from Insigs and insects. Nat Rev Mol Cell Biol 2003; 4: 631-640.
43. Porstmann T, Santos CR, Griffiths B, Cully M, Wu M, Leevers S et al. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab 2008; 8: 224-236.
44. Li W, Tai Y, Zhou J, Gu W, Bai Z, Zhou T et al. Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis. Cell Cycle 2012; 11: 2348-2358.
45. Ettinger SL, Sobel R, Whitmore TG, Akbari M, Bradley DR, Gleave ME et al. Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence. Cancer Res 2004; 64: 2212-2221.
46. Calvisi DF, Wang C, Ho C, Ladu S, Lee SA, Mattu S et al. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology 2011; 140: 1071-1083.
47. Yamashita T, Honda M, Takatori H, Nishino R, Minato H, Takamura H et al. Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma. J Hepatol 2009; 50: 100-110.